Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders

Alcoholism: Clinical and Experimental Research

Volumn 34, Issue 6, 2010, Pages 946-954

  Freeman, Willard M ^a   Vrana, Kent E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; MESSENGER RNA;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANALYTIC METHOD; BASIC RESEARCH; CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRINKING BEHAVIOR; HUMAN; LONGITUDINAL STUDY; MOLECULE; NATIONAL HEALTH ORGANIZATION; NONHUMAN; NOTE; ORGAN INJURY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; VALIDATION STUDY; ALCOHOL-RELATED DISORDERS; MEDICAL RESEARCH; METABOLISM; REPRODUCIBILITY; TRENDS; UNITED STATES;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; HUMANS; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (U.S.); REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 77952912527     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01169.x     Document Type: Note

References (55)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. American Psychiatric Association
2. Anderson L, Hunter CL (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5 : 573 588.
3. Anton RF, Lieber C, Tabakoff B (2002) Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26 : 1215 1222.
4. Baker M (2005) In biomarkers we trust? Nat Biotechnol 23 : 297 304.
5. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12 : 856 861.
6. Biermann T, Bonsch D, Reulbach U, Kornhuber J, Bleich S (2007) Dopamine and N-methyl-D-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal. J Neural Transm 114 : 1081 1084.
7. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69 : 89 95.
8. Blasio-Smith EA, Arai M, Quinet EM, Evans MJ, Kornaga T, Basso MD, Chen L, Feingold I, Halpern AR, Liu QY, Nambi P, Savio D, Wang S, Mounts WM, Isler JA, Slager AM, Burczynski ME, Dorner AJ, LaVallie ER (2008) Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med 6 : 59.
9. Bradford BU, O'Connell TM, Han J, Kosyk O, Shymonyak S, Ross PK, Winnike J, Kono H, Rusyn I (2008) Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol 232 : 236 243.
10. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR (2007) AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 31 : 1208 1217.
11. Brener ND, Billy JO, Grady WR (2003) Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature. J Adolesc Health 33 : 436 457.
12. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 158 : 1789 1795.
13. Conigrave KM, Davies P, Haber P, Whitfield JB (2003) Traditional markers of excessive alcohol use. Addiction 98 (Suppl. 2 31 43.
14. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26 : 332 339.
15. Connors GJ, Maisto SA (2003) Drinking reports from collateral individuals. Addiction 98 (Suppl. 2 21 29.
16. Das SK, Dhanya L, Vasudevan DM (2008) Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 68 : 81 92.
17. Dawson DA (2000) Drinking patterns among individuals with and without DSM-IV alcohol use disorders. J Stud Alcohol 61 : 111 120.
18. De GN, Donadio G, Chiarotti M (2007) The reliability of fatty acid ethyl esters (FAEE) as biological markers for the diagnosis of alcohol abuse. J Anal Toxicol 31 : 93 97.
19. DeAntoni E, Crawford ED, Stone NN, Blum DS, Berger ER, Eisenberger MA, Gambert SR, Staggers F (1993) Prostate Cancer Awareness Week, 1992: a summary of key findings. Clin Invest Med 16 : 448 457.
20. Dhalla S, Kopec JA (2007) The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med 30 : 33 41.
21. Ewing JA (1984) Detecting alcoholism. The CAGE questionnaire. JAMA 252 : 1905 1907.
22. Frank D, DeBenedetti AF, Volk RJ, Williams EC, Kivlahan DR, Bradley KA (2008) Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. J Gen Intern Med 23 : 781 787.
23. Freeman WM, Gooch RS, Lull ME, Worst TJ, Walker SJ, Xu AS, Green H, Pierre PJ, Grant KA, Vrana KE (2006) Apo-aii is an elevated biomarker of chronic non-human primate ethanol self-administration. Alcohol Alcohol 41 : 300 305.
24. Fuller RK, Lee KK, Gordis E (1988) Validity of self-report in alcoholism research: results of a Veterans Administration Cooperative Study. Alcohol Clin Exp Res 12 : 201 205.
25. Ghosh P, Hale EA, Lakshman MR (2001) Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker. Alcohol 25 : 173 179.
26. Giannini EG, Testa R, Savarino V (2005) Liver enzyme alteration: a guide for clinicians. CMAJ 172 : 367 379.
27. Golka K, Wiese A (2004) Carbohydrate-deficient transferrin (CDT) - a biomarker for long-term alcohol consumption. J Toxicol Environ Health B Crit Rev 7 : 319 337. (Pubitemid 38789290)
28. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ (2007) Biochemical markers of alcoholism. Clin Chem Lab Med 45 : 953 961.
29. Helander A (2003) Biological markers in alcoholism. J Neural Transm Suppl 66 : 15 32.
30. Helander A, Eriksson CJ (2002) Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res 26 : 1070 1077.
31. Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer C, Stecker G, Soyka M (2005) Validity of carbohydrate- deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100 : 1477 1486.
32. Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB, Helander A (2007) Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 45 : 558 562.
33. Kissack JC, Bishop J, Roper AL (2008) Ethylglucuronide as a biomarker for ethanol detection. Pharmacotherapy 28 : 769 781.
34. Koch H, Meerkerk GJ, Zaat JO, Ham MF, Scholten RJ, Assendelft WJ (2004) Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol Alcohol 39 : 75 85.
35. Korzec A, de BC, van LM (2005) The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use. J Clin Epidemiol 58 : 1024 1032.
36. Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2007) Compressing drug development timelines in oncology using phase '0' trials. Nat Rev Cancer 7 : 131 139.
37. Lesko LJ, Atkinson AJ (2001) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41 : 347 366.
38. Litten RZ (2009) Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res, Submitted.
39. Marrer E, Dieterle F (2007) Promises of biomarkers in drug development - a reality check. Chem Biol Drug Des 69 : 381 394.
40. Niemela O (2007) Biomarkers in alcoholism. Clin Chim Acta 377 : 39 49.
41. Nomura F, Tomonaga T, Sogawa K, Wu D, Ohashi T (2007) Application of proteomic technologies to discover and identify biomarkers for excessive alcohol consumption: a review. J Chromatogr B Analyt Technol Biomed Life Sci 855 : 35 41.
42. Pernanen K (1974) Validity of survey data on alcohol use, in Research Advances in Alcohol and Drug Problems (Gibbons R, Israël Y, Kalant H, Popham RE, Schmidt W, Smart RG eds. pp. 355 374. Wiley
43. Rao AR, Motiwala HG, Karim OM (2008) The discovery of prostate-specific antigen. BJU Int 101 : 5 10.
44. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13 : 1359 1362.
45. Rinck D, Frieling H, Freitag A, Hillemacher T, Bayerlein K, Kornhuber J, Bleich S (2007) Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol Depend 89 : 60 65.
46. Roche AM, Freeman T, Skinner N (2006) From data to evidence, to action: findings from a systematic review of hospital screening studies for high risk alcohol consumption. Drug Alcohol Depend 83 : 1 14.
47. Rolan P, Atkinson AJ, Lesko LJ (2003) Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development. Clin Pharmacol Ther 73 : 284 291.
48. Sakutata H, Suzuki T, Yasuda H, Ito T (2008) Beverage-specific effects of ethanol consumption on its biological markers. Clin Chem Lab Med 46 : 699 702.
49. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, Gilman S, Dumas YM, Calner P, Sebastiani P, Sridhar S, Beamis J, Lamb C, Anderson T, Gerry N, Keane J, Lenburg ME, Brody JS (2007) Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13 : 361 366.
50. Steinweg DL, Worth H (1993) Alcoholism: the keys to the CAGE. Am J Med 94 : 520 523.
51. Stephanson N, Helander A, Beck O (2007) Alcohol biomarker analysis: simultaneous determination of 5-hydroxytryptophol glucuronide and 5-hydroxyindoleacetic acid by direct injection of urine using ultra-performance liquid chromatography-tandem mass spectrometry. J Mass Spectrom 42 : 940 949.
52. Taracha E, Habrat B, Wozniak P, Walkowiak J, Szukalski B (2001) The activity of beta-hexosaminidase (uHex) and gamma-glutamyl-transferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects. World J Biol Psychiatry 2 : 184 189.
53. US Food and Drug Administration (2005) Guidance for Industry: Pharmacogenomic Data Submissions. US Food and Drug Administration
54. Walker SJ, Grant KA (2006) Peripheral blood alpha-synuclein mRNA levels are elevated in cynomolgus monkeys that chronically self-administer ethanol. Alcohol 38 : 1 4.
55. Williams SA, Slavin DE, Wagner JA, Webster CJ (2006) A cost-effectiveness approach to the qualification and acceptance of biomarkers. Nat Rev Drug Discov 5 : 897 902.